Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The Journal of Laryngology and Otology
|
April 16, 1998
Olfaction: a review
N Jones, D Rog
The British Journal of Dermatology
|
July 10, 2013
Alemtuzumab and chronic plaque psoriasis
A Aslam, A M Marsland, D Rog, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 24, 2015
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
C McGuigan, M Craner, J Guadagno, et al.
Multiple Sclerosis and Related Disorders
|
June 4, 2018
Validating the portal population of the United Kingdom Multiple Sclerosis Register
R M Middleton, W J Rodgers, J Chataway, et al.
The Lancet. Neurology
|
March 5, 2013
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
, K E Morrison, S Dhariwal, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The Journal of Laryngology and Otology
|
April 16, 1998
Olfaction: a review
N Jones, D Rog
The British Journal of Dermatology
|
July 10, 2013
Alemtuzumab and chronic plaque psoriasis
A Aslam, A M Marsland, D Rog, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 24, 2015
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
C McGuigan, M Craner, J Guadagno, et al.
Multiple Sclerosis and Related Disorders
|
June 4, 2018
Validating the portal population of the United Kingdom Multiple Sclerosis Register
R M Middleton, W J Rodgers, J Chataway, et al.
The Lancet. Neurology
|
March 5, 2013
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
, K E Morrison, S Dhariwal, et al.
Page
of 1